InfuSystem Holdings, Inc. (INFU) on Decifer Markets
Decifer Markets ranks INFU number 43 of 271 tracked names on durable business quality.
Why it ranks here
- It keeps about 17 cents of every sales dollar as cash, safer than 78 in 100 companies we measure.
- It earns about 9% a year on the money put into the business, better than 51 in 100 companies we measure.
- It costs about 32 times its yearly profit; the middle of its industry is 32. Cheaper than 48 in 100 companies we measure, against their own industries.
- It makes about 80 cents of gross profit a year on each dollar of assets, more than 96 in 100 companies we measure.
- Its share count fell about 2.8% over the last year. On not spreading the company over more shares it stands ahead of 79 in 100 companies we measure.
- Its assets shrank about 3% over the last year. On keeping expansion modest it stands ahead of 88 in 100 companies we measure.
- Its share price rose about 51% over the past year, leaving out the latest month. Stronger than 79 in 100 companies we measure.
The current read
The evidence on INFU lines up on the supportive side: the intelligence feed flags this name as connected to what is moving markets now. The independent signals we track are telling the same story.
Themes
- Robotic & Minimally-Invasive Intervention: Clinical and economic evidence favoring minimally invasive robotic and thrombectomy procedures is shifting procedure volumes and capital equipment budgets toward advanced interventional platforms.
Read the full INFU research brief · See all quality rankings
Intelligence data powered by Decifer. Not financial advice. For informational purposes only.